Webinars
Proven Expertise for Biologics Development, Manufacturing & Delivery with Capacity for Small Commercial Volume
Catalent Biologics’ Limoges, France development center is our European center of excellence for early phase clinical biologics formulation development and drug product fill/finish.
View Now
Webinars
Leveraging Advanced Technology & Proven Expertise from Cell Line Development & Beyond
Catalent’s mammalian cell line engineering and biomanufacturing capabilities, utilizing single-use systems, provide the flexibility and scalability needed to support our customers' growth.
View Now
Executive Summary
The Critical Role of Forced Degradation in Method Development, Manufacturability & CMC Strategy
Forced degradation studies are essential to the successful development of monoclonal antibodies (mAbs), bispecifics, and other biologics.
View Now
Presentation
SMARTag® Technology: Modular Design Solutions for Best-in-Class ADCs
Summary: Catalent’s SMARTag® Technology offers a versatile and innovative platform for the development of optimized antibody-drug conjugates (ADCs).
View Now
Webinars
From Bench to Patient Care: Unlocking iPSC Potential Through Innovative Science and Strategic Partnerships
Abstract: In the iPSC derived cell therapy world, developing a suitable iPSC line is a key step, but not the only one.
View Now
Webinars
Building Better Biologics: Overcoming Hurdles in Protein Therapy Manufacturing
This webinar will bring together industry leaders to discuss innovative strategies and practical solutions for manufacturing protein-based modality therapies.
View Now
Webinars
Critical Role of Forced Degradation in Method Development of mAbs
Forced degradation studies are crucial for developing recombinant monoclonal antibody therapeutics, aiding in everything from early manufacturability checks to comparability assessments before and after marketing approval.
View Now
Webinars
Catalent Biologics Analytical Services Capability Overview
Join Vincy Abraham, Director of Biologics Analytical Services, to discover how Catalent leverages its extensive expertise and capabilities to deliver tailored solutions to meet specific analytical needs for your biotherapeutics.
View Now
White Papers
UpTempo℠ Plasmid DNA Platform
Summary: Catalent has successfully addressed the challenges associated with plasmid DNA manufacturing by developing robust process and analytical platforms. Catalent’s approach involves a one-process-fits-all single-use (SU) manufacturing process in compliance with current good manufacturing practices (cGMP) standards.
View Now
Offering Fact Sheet
Speed Your Path to Patients with Integrated Solutions for Plasmid DNA Development & Manufacturing
Summary: Catalent offers extensive expertise in the bioproduction of plasmid DNA, from early stages of development to CGMP manufacturing to satisfy clinical and commercial needs.
View Now